Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bertelli

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
American Journal of Clinical Oncology|October 1, 1987
Sequential administration of cyclophosphamide, methotrexate, 5-fluorouracil, and folinic acid as salvage treatment in metastatic breast cancerP Pronzato, D Amoroso, A Ardizzoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1995
Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical studyG Bertelli, A Gozza, G B Forno, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
Intramuscular depot medroxyprogesterone versus oral megestrol for the control of postmenopausal hot flashes in breast cancer patients: a randomized studyG Bertelli, M Venturini, L Del Mastro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
Randomized phase III trial evaluating the role of erythropoietin in the prevention of chemotherapy-induced anemiaL Del Mastro, M Venturini, R Lionetto, et al.
Breast Cancer Research and Treatment|May 18, 1999
Effect of fenretinide on bone mineral density and metabolism in women with early breast cancerA Decensi, R Torrisi, A Gozza, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2017
GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the Anglo Celtic Group OPTION trialR C F Leonard, D J A Adamson, G Bertelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2000
Sequence effect of epirubicin and paclitaxel treatment on pharmacokinetics and toxicityM Venturini, G Lunardi, L Del Mastro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 20, 2009
The process of truth disclosure: an assessment of the results of information during the diagnostic phase in patients with cancerG Numico, M Anfossi, G Bertelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2001
Intensified chemotherapy supported by DMSO-free peripheral blood progenitor cells in breast cancer patientsL Del Mastro, M Venturini, C Viscoli, et al.
British Journal of Cancer|May 23, 2013
A decision impact, decision conflict and economic assessment of routine Oncotype DX testing of 146 women with node-negative or pNImi, ER-positive breast cancer in the U.KS Holt, G Bertelli, I Humphreys, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
American Journal of Clinical Oncology|October 1, 1987
Sequential administration of cyclophosphamide, methotrexate, 5-fluorouracil, and folinic acid as salvage treatment in metastatic breast cancerP Pronzato, D Amoroso, A Ardizzoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1995
Topical dimethylsulfoxide for the prevention of soft tissue injury after extravasation of vesicant cytotoxic drugs: a prospective clinical studyG Bertelli, A Gozza, G B Forno, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
Intramuscular depot medroxyprogesterone versus oral megestrol for the control of postmenopausal hot flashes in breast cancer patients: a randomized studyG Bertelli, M Venturini, L Del Mastro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
Randomized phase III trial evaluating the role of erythropoietin in the prevention of chemotherapy-induced anemiaL Del Mastro, M Venturini, R Lionetto, et al.
Breast Cancer Research and Treatment|May 18, 1999
Effect of fenretinide on bone mineral density and metabolism in women with early breast cancerA Decensi, R Torrisi, A Gozza, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 5, 2017
GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the Anglo Celtic Group OPTION trialR C F Leonard, D J A Adamson, G Bertelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2000
Sequence effect of epirubicin and paclitaxel treatment on pharmacokinetics and toxicityM Venturini, G Lunardi, L Del Mastro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 20, 2009
The process of truth disclosure: an assessment of the results of information during the diagnostic phase in patients with cancerG Numico, M Anfossi, G Bertelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2001
Intensified chemotherapy supported by DMSO-free peripheral blood progenitor cells in breast cancer patientsL Del Mastro, M Venturini, C Viscoli, et al.
British Journal of Cancer|May 23, 2013
A decision impact, decision conflict and economic assessment of routine Oncotype DX testing of 146 women with node-negative or pNImi, ER-positive breast cancer in the U.KS Holt, G Bertelli, I Humphreys, et al.
Pageof 10